Wasatch Advisors’s Argos Therapeutics, Inc. ARGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-32,163
Closed -$96K 322
2017
Q4
$96K Sell
32,163
-1,129
-3% -$3.79K ﹤0.01% 293
2017
Q3
$120K Buy
+33,292
New +$160K ﹤0.01% 324
2017
Q2
Sell
-9,345
Closed -$85K 365
2017
Q1
$85K Sell
9,345
-153,366
-94% -$9.71M ﹤0.01% 344
2016
Q4
$15.9M Buy
162,711
+1,274
+0.8% +$119K 0.24% 85
2016
Q3
$16M Buy
161,437
+42,013
+35% +$4.39M 0.24% 97
2016
Q2
$14.6M Sell
119,424
-943
-0.8% -$126K 0.22% 106
2016
Q1
$18.9M Buy
120,367
+6,557
+6% +$530K 0.29% 92
2015
Q4
$5.26M Sell
113,810
-1,126
-1% -$95.2K 0.07% 211
2015
Q3
$11.1M Buy
114,936
+7,784
+7% +$922K 0.15% 152
2015
Q2
$14.7M Sell
107,152
-1,430
-1% -$228K 0.16% 155
2015
Q1
$19.3M Buy
108,582
+35,796
+49% +$6.23M 0.2% 130
2014
Q4
$14.6M Buy
72,786
+14,869
+26% +$2.67M 0.15% 146
2014
Q3
$11.7M Sell
57,917
-4,193
-7% -$655K 0.12% 169
2014
Q2
$9.97M Buy
62,110
+239
+0.4% +$39.5K 0.1% 203
2014
Q1
$12.4M Buy
+61,871
New +$12.4M 0.12% 186

Other funds holding ARGS